JUN and hepatocellular carcinoma: The mechanisms of Sora resistant are complex and undefined, but include increased epidermal growth factor receptor (EGFR) expression, c-Jun and Akt activation of HCC cells, epithelial-mesenchymal transition (EMT), increased cancer stem cells, and an increase in the hypoxic environment [2, 5].